# A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine

> **NCT00501137** · PHASE3 · COMPLETED · sponsor: **Simon Dobson** · enrollment: 830 (actual)

## Conditions studied

- Cervical Cancer
- Genital Warts

## Interventions

- **BIOLOGICAL:** HPV (Human Papillomavirus) Vaccine

## Key facts

- **NCT ID:** NCT00501137
- **Lead sponsor:** Simon Dobson
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-02
- **Final completion:** 2010-12
- **Target enrollment:** 830 (ACTUAL)
- **Last updated:** 2015-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501137, "A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00501137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*